• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION JETSTREAM ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION JETSTREAM ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism/Embolus (4438)
Event Date 05/24/2023
Event Type  Injury  
Event Description
Elegance clinical study it was reported than an embolism occurred.The subject underwent treatment with the ranger drug coated balloon on (b)(6)2023 as a part of the elegance clinical trial.The target lesion was in right distal superficial femoral artery (sfa) with 5 mm proximal reference vessel diameter and 5 mm distal reference vessel diameter with lesion length of 400 mm and 70% stenosis and was classified as tasc ii c lesion.Prior to target lesion treatment with study device, atherectomy was performed using 5 mm x 200 mm jetstream 2.4/3.4 atherectomy device.Treatment of target lesion was performed by dilation using study device, 5 mm x 150 mm ranger drug coated balloon.Post treatment, the final residual stenosis was noted to be 5%.On (b)(6)2023, on the same day of index procedure, during the treatment of the target lesion, embolism was noted in the right popliteal artery due to 5 mm x 200 mm jetstream 2.4/3.4 atherectomy device.As a response to the complication, balloon dilation and cdt urokinase were performed.Post treatment, the final residual stenosis was noted to be 5%.The complication of embolism was resolved.On (b)(6) 2023, the subject was discharged on clopidogrel.
 
Manufacturer Narrative
A1 - patient identifier: (b)(6).Age at time of enrollment: 67 years old.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JETSTREAM ATHERECTOMY CATHETER
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17430421
MDR Text Key320112834
Report Number2124215-2023-39601
Device Sequence Number1
Product Code MCW
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 07/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/21/2023
Initial Date FDA Received07/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
Patient RaceAsian
-
-